Salivary IgG and IgA antibody levels (GMC; ng/ml) against vaccine serotypes in children after 2 doses, 2+1-doses of PCV7 or no PCV7 vaccinations (controls) at the age of 12 and 24 months.

Proportion of infants with IgG concentrations of ≥ 35µg/ml following 2 and 3 doses of PCV-7.

Stephanie A. Jones (451456)
Michelle Groome (451457)
Anthonet Koen (451458)
Nadia Van Niekerk (451459)
Poonam Sewraj (451460)
Locadiah Kuwanda (194694)
Alane Izu (392622)
Peter V. Adrian (198596)
Shabir A. Madhi (194703)

August 2013

<div>The proportion of infants with serum anti-capsular IgG antibody concentration ≥ 35µg/ml, a p...

Age-specific seroprevalence of IgG-Ptx concentrations in children 0–9 years of age in 1995-96 (upper figure) and in 2006-07 (lower figure).

Sabine C. de Greeff (339580)
Hester E. de Melker (120072)
Pieter G. M. van Gageldonk (359166)
Joop F. P. Schellekens (239594)
Fiona R. M. van der Klis (120069)
Liesbeth Mollema (359167)
Frits R. Mooi (133175)
Guy A. M. Berbers (120064)

February 2013

Note: on the x-axis the age-group, number tested and in brackets the percentage targeted by the a...

Geometric mean fold rise in antibody for PCV7-serotypes following PPV at age 9 months.

William S. Pomat (381258)
Anita H. J. van den Biggelaar (163091)
Suparat Phuanukoonnon (381259)
Jacinta Francis (381260)
Peter Jacoby (140921)
Peter M. Siba (136849)
Michael P. Alpers (214198)
John C. Reeder (137922)
Patrick G. Holt (136255)
Peter C. Richmond (112578)
Deborah Lehmann (381261)

February 2013

To demonstrate immunological memory, PPV was administered at 9 months of age and the mean (and 95...

Salivary IgA antibody levels (GMC; ng/ml) in children after 2 doses, 2+1-doses of PCV7 or no PCV7 vaccinations (controls) at the age of 12 and 24 months.

Gerwin D. Rodenburg (116716)
Elisabeth A. M. Sanders (104551)
Elske J. M. van Gils (126674)
Reinier H. Veenhoven (126687)
Tomasz Zborowski (302674)
Germie P. J. M. van den Dobbelsteen (156055)
Andries C. Bloem (302676)
Guy A. M. Berbers (120064)
Debby Bogaert (23222)

February 2013

α p-Values<0.05; 2+1 vs. 2-dose schedule.β p-Values<0.05; 2+1-dose vs. contr...

Salivary IgG antibody levels (GMC; ng/ml) in children after 2 doses, 2+1-doses of PCV7 or no PCV7 vaccinations (controls) at the age of 12 and 24 months.

Gerwin D. Rodenburg (116716)
Elisabeth A. M. Sanders (104551)
Elske J. M. van Gils (126674)
Reinier H. Veenhoven (126687)
Tomasz Zborowski (302674)
Germie P. J. M. van den Dobbelsteen (156055)
Andries C. Bloem (302676)
Guy A. M. Berbers (120064)
Debby Bogaert (23222)

February 2013

α p-Values<0.05; 2+1 vs. 2-dose schedule.β p-Values<0.05; 2+1-dose vs. contr...

Salivary Immune Responses to the 7-Valent Pneumococcal Conjugate Vaccine in the First 2 Years of Life

Rodenburg Gerwin D.
Sanders Elisabeth A. M.
van Gils Elske J. M.
Veenhoven Reinier H.
Zborowski Tomasz
van den Dobbelsteen Germie P. J. M.
Bloem Andries C.
Berbers Guy A. M.
Bogaert Debby

October 2012

The CRM197-conjugated 7-valent pneumococcal vaccine (PCV7) is protective against vaccine serotype di...

Salivary immune responses to the 7-valent pneumococcal conjugate vaccine in the first 2 years of life.

Gerwin D Rodenburg
Elisabeth A M Sanders
Elske J M van Gils
Reinier H Veenhoven
Tomasz Zborowski
Germie P J M van den Dobbelsteen
Andries C Bloem
Guy A M Berbers
Debby Bogaert

The CRM197-conjugated 7-valent pneumococcal vaccine (PCV7) is protective against vaccine serotype di...

Age-specific geometric mean serotype-specific antibody concentrations pre-and post-PCV7 at 0-1-2 or 1-2-3-months or no PCV7.

William S. Pomat (381258)
Anita H. J. van den Biggelaar (163091)
Suparat Phuanukoonnon (381259)
Jacinta Francis (381260)
Peter Jacoby (140921)
Peter M. Siba (136849)
Michael P. Alpers (214198)
John C. Reeder (137922)
Patrick G. Holt (136255)
Peter C. Richmond (112578)
Deborah Lehmann (381261)

February 2013

Geometric mean (GM) concentrations and 95% confidence intervals of serotype-specific IgG antibodi...

Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster dose

van Westen, Els
Rodenburg, Gerwin D.
van Gils, Elske J.M.
Tcherniaeva, Irina
Berbers, Guy A.M.
Cowell, Lucy
Goldblatt, David
Rots, Nynke Y.
van den Dobbelsteen, Germie P.J.M.
Sanders, Elisabeth A.M.

December 2013

AbstractThe seven-valent pneumococcal conjugate vaccine (PCV7) has been introduced in most high-inco...

CONCISE COMMUNICATIONS The Effect of Age and Natural Priming on the IgG and IgA Subclass Responses after Parenteral In¯uenza Vaccination

Abdullah S. El-madhun
A Rebecca J. Cox
Lars R. Haaheim

January 1999

This study investigated the effect of natural priming and age on serum IgG and IgA subclass response...

Seroprevalence of measles-, mumps- and rubella lgG antibody titres in children by documentation of vaccinations and by vaccination status (children with documentation of vaccinations).

Christina Poethko-Müller (312362)
Annette Mankertz (312365)

February 2013

Seroprevalence of measles-, mumps- and rubella lgG antibody titres in children by documentation o...

IMBALANCE OF IgG SUBCLASSES IN PRESCHOOL CHILDREN WITH A DIFFERENT TYPE OF VACCINE RESPONSE TO MMR

Smilianska, M. V.

October 2019

Introduction. The only way to protect children against measles, mups and rubella viruses (MMR) is va...

Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 doses

Rodenburg, Gerwin D
van Gils, Elske J M
Veenhoven, Reinier H
Jones, Nienke
Tcherniaeva, Irina
Hak, Eelko
van Alphen, Loek
Berbers, Guy A M
Sanders, Elisabeth A M

February 2010

In this cohort study we compared IgG antibody levels between infants immunized with 7-valent CRM197-...

Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming : systemically induced local immunity and saliva as potential surveillance tool

Stoof, Susanne P
van der Klis, Fiona R M
van Rooijen, Debbie M
Bogaert, Debby
Trzcinski, Krzysztof
Sanders, Elisabeth A M
Berbers, Guy A M

July 2015

BACKGROUND: In several countries large-scale immunization of children and young adults with Meningoc...

Secretory and serum immunoglobulin class-specific antibodies to poliovirus after vaccination

B. Carlsson
Shakila Zaman
L. Mell
Fehmida Jalil
L. A. Hanson

January 1985

Immune responses in serum and saliva were studied in Pakistani children by enzyme-linked immunosorbe...

Proportion of infants with IgG concentrations of ≥ 35µg/ml following 2 and 3 doses of PCV-7.

Stephanie A. Jones (451456)
Michelle Groome (451457)
Anthonet Koen (451458)
Nadia Van Niekerk (451459)
Poonam Sewraj (451460)
Locadiah Kuwanda (194694)
Alane Izu (392622)
Peter V. Adrian (198596)
Shabir A. Madhi (194703)

August 2013

<div>The proportion of infants with serum anti-capsular IgG antibody concentration ≥ 35µg/ml, a p...

Age-specific seroprevalence of IgG-Ptx concentrations in children 0–9 years of age in 1995-96 (upper figure) and in 2006-07 (lower figure).

Sabine C. de Greeff (339580)
Hester E. de Melker (120072)
Pieter G. M. van Gageldonk (359166)
Joop F. P. Schellekens (239594)
Fiona R. M. van der Klis (120069)
Liesbeth Mollema (359167)
Frits R. Mooi (133175)
Guy A. M. Berbers (120064)

February 2013

Note: on the x-axis the age-group, number tested and in brackets the percentage targeted by the a...

Geometric mean fold rise in antibody for PCV7-serotypes following PPV at age 9 months.

William S. Pomat (381258)
Anita H. J. van den Biggelaar (163091)
Suparat Phuanukoonnon (381259)
Jacinta Francis (381260)
Peter Jacoby (140921)
Peter M. Siba (136849)
Michael P. Alpers (214198)
John C. Reeder (137922)
Patrick G. Holt (136255)
Peter C. Richmond (112578)
Deborah Lehmann (381261)

February 2013

To demonstrate immunological memory, PPV was administered at 9 months of age and the mean (and 95...

Salivary IgA antibody levels (GMC; ng/ml) in children after 2 doses, 2+1-doses of PCV7 or no PCV7 vaccinations (controls) at the age of 12 and 24 months.

Gerwin D. Rodenburg (116716)
Elisabeth A. M. Sanders (104551)
Elske J. M. van Gils (126674)
Reinier H. Veenhoven (126687)
Tomasz Zborowski (302674)
Germie P. J. M. van den Dobbelsteen (156055)
Andries C. Bloem (302676)
Guy A. M. Berbers (120064)
Debby Bogaert (23222)

February 2013

α p-Values<0.05; 2+1 vs. 2-dose schedule.β p-Values<0.05; 2+1-dose vs. contr...

Salivary IgG antibody levels (GMC; ng/ml) in children after 2 doses, 2+1-doses of PCV7 or no PCV7 vaccinations (controls) at the age of 12 and 24 months.

Gerwin D. Rodenburg (116716)
Elisabeth A. M. Sanders (104551)
Elske J. M. van Gils (126674)
Reinier H. Veenhoven (126687)
Tomasz Zborowski (302674)
Germie P. J. M. van den Dobbelsteen (156055)
Andries C. Bloem (302676)
Guy A. M. Berbers (120064)
Debby Bogaert (23222)

February 2013

α p-Values<0.05; 2+1 vs. 2-dose schedule.β p-Values<0.05; 2+1-dose vs. contr...

Salivary Immune Responses to the 7-Valent Pneumococcal Conjugate Vaccine in the First 2 Years of Life

Rodenburg Gerwin D.
Sanders Elisabeth A. M.
van Gils Elske J. M.
Veenhoven Reinier H.
Zborowski Tomasz
van den Dobbelsteen Germie P. J. M.
Bloem Andries C.
Berbers Guy A. M.
Bogaert Debby

October 2012

The CRM197-conjugated 7-valent pneumococcal vaccine (PCV7) is protective against vaccine serotype di...

Salivary immune responses to the 7-valent pneumococcal conjugate vaccine in the first 2 years of life.

Gerwin D Rodenburg
Elisabeth A M Sanders
Elske J M van Gils
Reinier H Veenhoven
Tomasz Zborowski
Germie P J M van den Dobbelsteen
Andries C Bloem
Guy A M Berbers
Debby Bogaert

The CRM197-conjugated 7-valent pneumococcal vaccine (PCV7) is protective against vaccine serotype di...

Age-specific geometric mean serotype-specific antibody concentrations pre-and post-PCV7 at 0-1-2 or 1-2-3-months or no PCV7.

William S. Pomat (381258)
Anita H. J. van den Biggelaar (163091)
Suparat Phuanukoonnon (381259)
Jacinta Francis (381260)
Peter Jacoby (140921)
Peter M. Siba (136849)
Michael P. Alpers (214198)
John C. Reeder (137922)
Patrick G. Holt (136255)
Peter C. Richmond (112578)
Deborah Lehmann (381261)

February 2013

Geometric mean (GM) concentrations and 95% confidence intervals of serotype-specific IgG antibodi...

Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster dose

van Westen, Els
Rodenburg, Gerwin D.
van Gils, Elske J.M.
Tcherniaeva, Irina
Berbers, Guy A.M.
Cowell, Lucy
Goldblatt, David
Rots, Nynke Y.
van den Dobbelsteen, Germie P.J.M.
Sanders, Elisabeth A.M.

December 2013

AbstractThe seven-valent pneumococcal conjugate vaccine (PCV7) has been introduced in most high-inco...

CONCISE COMMUNICATIONS The Effect of Age and Natural Priming on the IgG and IgA Subclass Responses after Parenteral In¯uenza Vaccination

Abdullah S. El-madhun
A Rebecca J. Cox
Lars R. Haaheim

January 1999

This study investigated the effect of natural priming and age on serum IgG and IgA subclass response...

Seroprevalence of measles-, mumps- and rubella lgG antibody titres in children by documentation of vaccinations and by vaccination status (children with documentation of vaccinations).

Christina Poethko-Müller (312362)
Annette Mankertz (312365)

February 2013

Seroprevalence of measles-, mumps- and rubella lgG antibody titres in children by documentation o...

IMBALANCE OF IgG SUBCLASSES IN PRESCHOOL CHILDREN WITH A DIFFERENT TYPE OF VACCINE RESPONSE TO MMR

Smilianska, M. V.

October 2019

Introduction. The only way to protect children against measles, mups and rubella viruses (MMR) is va...

Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 doses

Rodenburg, Gerwin D
van Gils, Elske J M
Veenhoven, Reinier H
Jones, Nienke
Tcherniaeva, Irina
Hak, Eelko
van Alphen, Loek
Berbers, Guy A M
Sanders, Elisabeth A M

February 2010

In this cohort study we compared IgG antibody levels between infants immunized with 7-valent CRM197-...

Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming : systemically induced local immunity and saliva as potential surveillance tool

Stoof, Susanne P
van der Klis, Fiona R M
van Rooijen, Debbie M
Bogaert, Debby
Trzcinski, Krzysztof
Sanders, Elisabeth A M
Berbers, Guy A M

July 2015

BACKGROUND: In several countries large-scale immunization of children and young adults with Meningoc...

Secretory and serum immunoglobulin class-specific antibodies to poliovirus after vaccination

B. Carlsson
Shakila Zaman
L. Mell
Fehmida Jalil
L. A. Hanson

January 1985

Immune responses in serum and saliva were studied in Pakistani children by enzyme-linked immunosorbe...

Proportion of infants with IgG concentrations of ≥ 35µg/ml following 2 and 3 doses of PCV-7.

Stephanie A. Jones (451456)
Michelle Groome (451457)
Anthonet Koen (451458)
Nadia Van Niekerk (451459)
Poonam Sewraj (451460)
Locadiah Kuwanda (194694)
Alane Izu (392622)
Peter V. Adrian (198596)
Shabir A. Madhi (194703)

August 2013

<div>The proportion of infants with serum anti-capsular IgG antibody concentration ≥ 35µg/ml, a p...

Age-specific seroprevalence of IgG-Ptx concentrations in children 0–9 years of age in 1995-96 (upper figure) and in 2006-07 (lower figure).

Sabine C. de Greeff (339580)
Hester E. de Melker (120072)
Pieter G. M. van Gageldonk (359166)
Joop F. P. Schellekens (239594)
Fiona R. M. van der Klis (120069)
Liesbeth Mollema (359167)
Frits R. Mooi (133175)
Guy A. M. Berbers (120064)

February 2013

Note: on the x-axis the age-group, number tested and in brackets the percentage targeted by the a...

Geometric mean fold rise in antibody for PCV7-serotypes following PPV at age 9 months.

William S. Pomat (381258)
Anita H. J. van den Biggelaar (163091)
Suparat Phuanukoonnon (381259)
Jacinta Francis (381260)
Peter Jacoby (140921)
Peter M. Siba (136849)
Michael P. Alpers (214198)
John C. Reeder (137922)
Patrick G. Holt (136255)
Peter C. Richmond (112578)
Deborah Lehmann (381261)

February 2013

To demonstrate immunological memory, PPV was administered at 9 months of age and the mean (and 95...

Salivary IgG and IgA antibody levels (GMC; ng/ml) against vaccine serotypes in children after 2 doses, 2+1-doses of PCV7 or no PCV7 vaccinations (controls) at the age of 12 and 24 months.

Abstract

Extracted data

Salivary IgG and IgA antibody levels (GMC; ng/ml) against vaccine serotypes in children after 2 doses, 2+1-doses of PCV7 or no PCV7 vaccinations (controls) at the age of 12 and 24 months.

Abstract

Extracted data

Related items

Related items